{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:11:22Z","timestamp":1792458682424,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":164,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811043031","type":"print"},{"value":"9789811043048","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-4304-8_12","type":"book-chapter","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T15:01:10Z","timestamp":1509634870000},"page":"187-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection"],"prefix":"10.1007","author":[{"given":"Kate L.","family":"Weeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca C.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Y. Y.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"12_CR1","unstructured":"Zak R (1984) In: Growth of the heart in health and disease. Raven Press, New York, pp 1\u201324, 131\u2013185, 381\u2013420"},{"issue":"11","key":"12_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s001090050275","volume":"76","author":"PH Sugden","year":"1998","unstructured":"Sugden PH, Clerk A (1998) Cellular mechanisms of cardiac hypertrophy. J Mol Med 76(11):725\u2013746","journal-title":"J Mol Med"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev.ph.49.030187.002441","volume":"49","author":"G Cooper","year":"1987","unstructured":"Cooper G (1987) Cardiocyte adaptation to chronically altered load. Annu Rev Physiol 49:501\u2013518","journal-title":"Annu Rev Physiol"},{"issue":"17","key":"12_CR4","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","volume":"341","author":"JJ Hunter","year":"1999","unstructured":"Hunter JJ, Chien KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341(17):1276\u20131283","journal-title":"N Engl J Med"},{"issue":"22","key":"12_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD et al (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22):1561\u20131566","journal-title":"N Engl J Med"},{"issue":"6","key":"12_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.104.492033","volume":"113","author":"WH Barker","year":"2006","unstructured":"Barker WH, Mullooly JP, Getchell W (2006) Changing incidence and survival for heart failure in a well-defined older population, 1970\u20131974 and 1990\u20131994. Circulation 113(6):799\u2013805","journal-title":"Circulation"},{"issue":"3","key":"12_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.hlc.2004.06.007","volume":"13","author":"RA Clark","year":"2004","unstructured":"Clark RA, McLennan S, Dawson A et al (2004) Uncovering a hidden epidemic: a study of the current burden of heart failure in Australia. Heart Lung Circ 13(3):266\u2013273","journal-title":"Heart Lung Circ"},{"issue":"6","key":"12_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.tcm.2014.12.014","volume":"25","author":"X Wei","year":"2015","unstructured":"Wei X, Liu X, Rosenzweig A (2015) What do we know about the cardiac benefits of exercise? Trends Cardiovasc Med 25(6):529\u2013536","journal-title":"Trends Cardiovasc Med"},{"issue":"17","key":"12_CR9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/jama.1989.03430170057028","volume":"262","author":"SN Blair","year":"1989","unstructured":"Blair SN, Kohl HW 3rd, Paffenbarger RS Jr et al (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262(17):2395\u20132401","journal-title":"JAMA"},{"issue":"19","key":"12_CR10","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Tanaka S et al (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301(19):2024\u20132035","journal-title":"JAMA"},{"issue":"23","key":"12_CR11","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1161\/CIRCULATIONAHA.111.038422","volume":"124","author":"DC Lee","year":"2011","unstructured":"Lee DC, Sui X, Artero EG et al (2011) Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation 124(23):2483\u20132490","journal-title":"Circulation"},{"issue":"5 Pt 2","key":"12_CR12","first-page":"H2183","volume":"271","author":"MH Soonpaa","year":"1996","unstructured":"Soonpaa MH, Kim KK, Pajak L et al (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Phys 271(5 Pt 2):H2183\u2013H2189","journal-title":"Am J Phys"},{"issue":"21","key":"12_CR13","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1073\/pnas.1934654100","volume":"100","author":"JR McMullen","year":"2003","unstructured":"McMullen JR, Shioi T, Zhang L et al (2003) Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100(21):12355\u201312360","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L et al (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128(1):191\u2013227","journal-title":"Pharmacol Ther"},{"issue":"3","key":"12_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cvr\/27.3.341","volume":"27","author":"KT Weber","year":"1993","unstructured":"Weber KT, Brilla CG, Janicki JS (1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27(3):341\u2013348","journal-title":"Cardiovasc Res"},{"issue":"4","key":"12_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/01.CIR.95.4.766","volume":"95","author":"JN Cohn","year":"1997","unstructured":"Cohn JN, Bristow MR, Chien KR et al (1997) Report of the national heart, lung, and blood institute special emphasis panel on heart failure research. Circulation 95(4):766\u2013770","journal-title":"Circulation"},{"issue":"2","key":"12_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1152\/physrev.1992.72.2.369","volume":"72","author":"O Hudlicka","year":"1992","unstructured":"Hudlicka O, Brown M, Egginton S (1992) Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72(2):369\u2013417","journal-title":"Physiol Rev"},{"key":"12_CR18","volume-title":"Growth of the heart in health and disease","author":"TF Schaible","year":"1984","unstructured":"Schaible TF, Scheuer J (1984) Response of the heart to exercise training. In: Zak R (ed) Growth of the heart in health and disease. Raven Press, New York"},{"key":"12_CR19","first-page":"187","volume-title":"Growth of the heart in health and disease","author":"VJ Ferrans","year":"1984","unstructured":"Ferrans VJ (1984) Cardiac hypertrophy: morphological aspects. In: Zak R (ed) Growth of the heart in health and disease. Raven Press, New York, pp 187\u2013239"},{"issue":"3","key":"12_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0733-8651(05)70348-9","volume":"15","author":"RH Fagard","year":"1997","unstructured":"Fagard RH (1997) Impact of different sports and training on cardiac structure and function. Cardiol Clin 15(3):397\u2013412","journal-title":"Cardiol Clin"},{"issue":"15","key":"12_CR21","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1096\/fasebj.5.15.1835945","volume":"5","author":"KR Chien","year":"1991","unstructured":"Chien KR, Knowlton KU, Zhu H et al (1991) Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5(15):3037\u20133046","journal-title":"FASEB J"},{"issue":"2","key":"12_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1073\/pnas.85.2.339","volume":"85","author":"S Izumo","year":"1988","unstructured":"Izumo S, Nadal-Ginard B, Mahdavi V (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A 85(2):339\u2013343","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.physiol.62.1.289","volume":"62","author":"WR MacLellan","year":"2000","unstructured":"MacLellan WR, Schneider MD (2000) Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62:289\u2013319","journal-title":"Annu Rev Physiol"},{"key":"12_CR24","first-page":"57","volume-title":"Heart Failure","author":"SK Gunasinghe","year":"2004","unstructured":"Gunasinghe SK, Spinale FG (2004) Myocardial basis for heart failure: role of the cardiac interstitium. In: Mann DL (ed) Heart Failure. Saunders, Philadelphia, pp 57\u201370"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","volume":"63","author":"JD Molkentin","year":"2001","unstructured":"Molkentin JD, Dorn IG 2nd (2001) Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391\u2013426","journal-title":"Annu Rev Physiol"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45\u201379","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"12_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7(8):589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"12_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY et al (2015) Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol 89(9):1401\u20131438","journal-title":"Arch Toxicol"},{"issue":"11","key":"12_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/hh2301.100982","volume":"89","author":"GG Neri Serneri","year":"2001","unstructured":"Neri Serneri GG, Boddi M, Modesti PA et al (2001) Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 89(11):977\u2013982","journal-title":"Circ Res"},{"issue":"1","key":"12_CR30","first-page":"67","volume":"8","author":"A Zebrowska","year":"2009","unstructured":"Zebrowska A, Gasior Z, Langfort J (2009) Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy. J Sports Sci Med 8(1):67\u201376","journal-title":"J Sports Sci Med"},{"issue":"2","key":"12_CR31","first-page":"116","volume":"34","author":"A Zebrowska","year":"2013","unstructured":"Zebrowska A, Waskiewicz Z, Zajac A et al (2013) IGF-1 response to arm exercise with eccentric and concentric muscle contractions in resistance-trained athletes with left ventricular hypertrophy. Int J Sports Med 34(2):116\u2013122","journal-title":"Int J Sports Med"},{"issue":"11","key":"12_CR32","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1210\/me.2008-0265","volume":"22","author":"J Kim","year":"2008","unstructured":"Kim J, Wende AR, Sena S et al (2008) Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol 22(11):2531\u20132543","journal-title":"Mol Endocrinol"},{"issue":"6","key":"12_CR33","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1074\/jbc.M310405200","volume":"279","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Shioi T, Huang W-Y et al (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 279(6):4782\u20134793","journal-title":"J Biol Chem"},{"issue":"8","key":"12_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7(8):606\u2013619","journal-title":"Nat Rev Genet"},{"issue":"5","key":"12_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrm2882","volume":"11","author":"B Vanhaesebroeck","year":"2010","unstructured":"Vanhaesebroeck B, Guillermet-Guibert J, Graupera M et al (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11(5):329\u2013341","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"12_CR36","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/MCB.16.5.2195","volume":"16","author":"DA Antonetti","year":"1996","unstructured":"Antonetti DA, Algenstaedt P, Kahn CR (1996) Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol Cell Biol 16(5):2195\u20132203","journal-title":"Mol Cell Biol"},{"issue":"1","key":"12_CR37","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1152\/ajpendo.2001.280.1.E65","volume":"280","author":"A Kessler","year":"2001","unstructured":"Kessler A, Uphues I, Ouwens DM et al (2001) Diversification of cardiac insulin signaling involves the p85 alpha\/beta subunits of phosphatidylinositol 3-kinase. Am J Physiol Endocrinol Metab 280(1):E65\u2013E74","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"22","key":"12_CR38","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/CIRCULATIONAHA.107.706515","volume":"116","author":"C Perrino","year":"2007","unstructured":"Perrino C, Schroder JN, Lima B et al (2007) Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. Circulation 116(22):2571\u20132579","journal-title":"Circulation"},{"issue":"4","key":"12_CR39","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1152\/jappl.1999.86.4.1436","volume":"86","author":"LP Koziris","year":"1999","unstructured":"Koziris LP, Hickson RC, Chatterton RT Jr et al (1999) Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 86(4):1436\u20131442","journal-title":"J Appl Physiol"},{"issue":"4","key":"12_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s002230010060","volume":"66","author":"Y Kodama","year":"2000","unstructured":"Kodama Y, Umemura Y, Nagasawa S et al (2000) Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL\/6 J mice but not in C3H\/Hej mice. Calcif Tissue Int 66(4):298\u2013306","journal-title":"Calcif Tissue Int"},{"issue":"1 Pt 1","key":"12_CR41","first-page":"E129","volume":"266","author":"JK Yeh","year":"1994","unstructured":"Yeh JK, Aloia JF, Chen M et al (1994) Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. Am J Phys 266(1 Pt 1):E129\u2013E135","journal-title":"Am J Phys"},{"issue":"6165","key":"12_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/332644a0","volume":"332","author":"M Whitman","year":"1988","unstructured":"Whitman M, Downes CP, Keeler M et al (1988) Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332(6165):644\u2013646","journal-title":"Nature"},{"issue":"Pt 3","key":"12_CR43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1042\/bj3150709","volume":"315","author":"SR James","year":"1996","unstructured":"James SR, Downes CP, Gigg R et al (1996) Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem J 315(Pt 3):709\u2013713","journal-title":"Biochem J"},{"issue":"4","key":"12_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","volume":"7","author":"DR Alessi","year":"1997","unstructured":"Alessi DR, James SR, Downes CP et al (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7(4):261\u2013269","journal-title":"Curr Biol"},{"issue":"50","key":"12_CR45","doi-asserted-by":"publisher","first-page":"31515","DOI":"10.1074\/jbc.272.50.31515","volume":"272","author":"M Andjelkovic","year":"1997","unstructured":"Andjelkovic M, Alessi DR, Meier R et al (1997) Role of translocation in the activation and function of protein kinase B. J Biol Chem 272(50):31515\u201331524","journal-title":"J Biol Chem"},{"issue":"4","key":"12_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050095","volume":"5","author":"V Calleja","year":"2007","unstructured":"Calleja V, Alcor D, Laguerre M et al (2007) Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 5(4):e95","journal-title":"PLoS Biol"},{"issue":"21","key":"12_CR47","doi-asserted-by":"publisher","first-page":"9491","DOI":"10.1128\/MCB.25.21.9491-9502.2005","volume":"25","author":"J Luo","year":"2005","unstructured":"Luo J, McMullen JR, Sobkiw CL et al (2005) Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25(21):9491\u20139502","journal-title":"Mol Cell Biol"},{"issue":"4","key":"12_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.109.873380","volume":"120","author":"Z Lu","year":"2009","unstructured":"Lu Z, Jiang Y-P, Wang W et al (2009) Loss of cardiac phosphoinositide 3-Kinase p110{alpha} results in contractile dysfunction. Circulation 120(4):318\u2013325","journal-title":"Circulation"},{"issue":"11","key":"12_CR49","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","volume":"19","author":"T Shioi","year":"2000","unstructured":"Shioi T, Kang PM, Douglas PS et al (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19(11):2537\u20132548","journal-title":"EMBO J"},{"issue":"4","key":"12_CR50","doi-asserted-by":"publisher","first-page":"H1690","DOI":"10.1152\/ajpheart.00531.2008","volume":"295","author":"N Yano","year":"2008","unstructured":"Yano N, Tseng A, Zhao TC et al (2008) Temporally controlled overexpression of cardiac-specific PI3Kalpha induces enhanced myocardial contractility\u2013a new transgenic model. Am J Physiol Heart Circ Physiol 295(4):H1690\u2013H1694","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"12_CR51","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1172\/JCI25397","volume":"116","author":"C Perrino","year":"2006","unstructured":"Perrino C, Naga Prasad SV, Mao L et al (2006) Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116(6):1547\u20131560","journal-title":"J Clin Invest"},{"issue":"4","key":"12_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCHEARTFAILURE.112.966622","volume":"5","author":"KL Weeks","year":"2012","unstructured":"Weeks KL, Gao X, Du XJ et al (2012) Phosphoinositide 3-Kinase p110alpha is a master regulator of exercise-induced cardioprotection and pi3k gene therapy rescues cardiac dysfunction. Circ Heart Fail 5(4):523\u2013534","journal-title":"Circ Heart Fail"},{"issue":"7","key":"12_CR53","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","volume":"143","author":"P Bostrom","year":"2010","unstructured":"Bostrom P, Mann N, Wu J et\u00a0al (2010) C\/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143(7):1072\u20131083","journal-title":"Cell"},{"issue":"8","key":"12_CR54","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.exger.2006.05.008","volume":"41","author":"B Rinaldi","year":"2006","unstructured":"Rinaldi B, Corbi G, Boccuti S et al (2006) Exercise training affects age-induced changes in SOD and heat shock protein expression in rat heart. Exp Gerontol 41(8):764\u2013770","journal-title":"Exp Gerontol"},{"issue":"13\u201314","key":"12_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.lfs.2012.01.018","volume":"90","author":"CA Pinho","year":"2012","unstructured":"Pinho CA, Tromm CB, Tavares AM et al (2012) Effects of different physical training protocols on ventricular oxidative stress parameters in infarction-induced rats. Life Sci 90(13\u201314):553\u2013559","journal-title":"Life Sci"},{"issue":"3","key":"12_CR56","doi-asserted-by":"publisher","first-page":"H1346","DOI":"10.1152\/ajpheart.2001.281.3.H1346","volume":"281","author":"KL Hamilton","year":"2001","unstructured":"Hamilton KL, Powers SK, Sugiura T et al (2001) Short-term exercise training can improve myocardial tolerance to I\/R without elevation in heat shock proteins. Am J Physiol Heart Circ Physiol 281(3):H1346\u2013H1352","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"12_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2012.05.014","volume":"53","author":"T Chen","year":"2012","unstructured":"Chen T, Jin X, Crawford BH et al (2012) Cardioprotection from oxidative stress in the newborn heart by activation of PPARgamma is mediated by catalase. Free Radic Biol Med 53(2):208\u2013215","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"12_CR58","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/10715760903159154","volume":"43","author":"MJ Frederico","year":"2009","unstructured":"Frederico MJ, Justo SL, Da Luz G et al (2009) Exercise training provides cardioprotection via a reduction in reactive oxygen species in rats submitted to myocardial infarction induced by isoproterenol. Free Radic Res 43(10):957\u2013964","journal-title":"Free Radic Res"},{"issue":"1","key":"12_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/SHK.0b013e318199165d","volume":"32","author":"W You","year":"2009","unstructured":"You W, Min X, Zhang X et al (2009) Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K\/Akt-dependent mechanism. Shock 32(1):108\u2013117","journal-title":"Shock"},{"issue":"5","key":"12_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00421-008-0833-4","volume":"104","author":"MB Harris","year":"2008","unstructured":"Harris MB, Mitchell BM, Sood SG et al (2008) Increased nitric oxide synthase activity and Hsp90 association in skeletal muscle following chronic exercise. Eur J Appl Physiol 104(5):795\u2013802","journal-title":"Eur J Appl Physiol"},{"issue":"21","key":"12_CR61","doi-asserted-by":"publisher","first-page":"12610","DOI":"10.1074\/jbc.271.21.12610","volume":"271","author":"YJ Kang","year":"1996","unstructured":"Kang YJ, Chen Y, Epstein PN (1996) Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271(21):12610\u201312616","journal-title":"J Biol Chem"},{"issue":"4","key":"12_CR62","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/ATVBAHA.109.201988","volume":"30","author":"RC Lin","year":"2010","unstructured":"Lin RC, Weeks KL, Gao XM et al (2010) PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30(4):724\u2013732","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5712","key":"12_CR63","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM et al (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307(5712):1098\u20131101","journal-title":"Science"},{"issue":"17","key":"12_CR64","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1128\/MCB.22.17.6247-6260.2002","volume":"22","author":"MP Scheid","year":"2002","unstructured":"Scheid MP, Marignani PA, Woodgett JR (2002) Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol Cell Biol 22(17):6247\u20136260","journal-title":"Mol Cell Biol"},{"issue":"23","key":"12_CR65","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","volume":"15","author":"DR Alessi","year":"1996","unstructured":"Alessi DR, Andjelkovic M, Caudwell B et al (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15(23):6541\u20136551","journal-title":"EMBO J"},{"issue":"6559","key":"12_CR66","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P et al (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785\u2013789","journal-title":"Nature"},{"issue":"4","key":"12_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/sj.onc.1209812","volume":"26","author":"M Rosner","year":"2007","unstructured":"Rosner M, Freilinger A, Hengstschlager M (2007) Akt regulates nuclear\/cytoplasmic localization of tuberin. Oncogene 26(4):521\u2013531","journal-title":"Oncogene"},{"issue":"1","key":"12_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN et al (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell 10(1):151\u2013162","journal-title":"Mol Cell"},{"issue":"9","key":"12_CR69","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T et al (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648\u2013657","journal-title":"Nat Cell Biol"},{"issue":"3","key":"12_CR70","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1152\/physrev.00024.2010","volume":"91","author":"MA Sussman","year":"2011","unstructured":"Sussman MA, Volkers M, Fischer K et al (2011) Myocardial AKT: the omnipresent nexus. Physiol Rev 91(3):1023\u20131070","journal-title":"Physiol Rev"},{"issue":"17","key":"12_CR71","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","volume":"113","author":"B DeBosch","year":"2006","unstructured":"DeBosch B, Treskov I, Lupu TS et al (2006) Akt1 is required for physiological cardiac growth. Circulation 113(17):2097\u20132104","journal-title":"Circulation"},{"issue":"8","key":"12_CR72","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1128\/MCB.22.8.2799-2809.2002","volume":"22","author":"T Shioi","year":"2002","unstructured":"Shioi T, McMullen JR, Kang PM et al (2002) Akt\/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22(8):2799\u20132809","journal-title":"Mol Cell Biol"},{"issue":"25","key":"12_CR73","doi-asserted-by":"publisher","first-page":"22896","DOI":"10.1074\/jbc.M200347200","volume":"277","author":"T Matsui","year":"2002","unstructured":"Matsui T, Li L, Wu JC et al (2002) Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277(25):22896\u201322901","journal-title":"J Biol Chem"},{"issue":"19","key":"12_CR74","doi-asserted-by":"publisher","first-page":"12333","DOI":"10.1073\/pnas.172376399","volume":"99","author":"G Condorelli","year":"2002","unstructured":"Condorelli G, Drusco A, Stassi G et al (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99(19):12333\u201312338","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"12_CR75","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/01.RES.0000124394.01180.BE","volume":"94","author":"I Shiraishi","year":"2004","unstructured":"Shiraishi I, Melendez J, Ahn Y et al (2004) Nuclear targeting of Akt Enhances Kinase activity and survival of cardiomyocytes. Circ Res 94(7):884\u2013891","journal-title":"Circ Res"},{"issue":"24","key":"12_CR76","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev 20(24):3347\u20133365","journal-title":"Genes Dev"},{"issue":"48","key":"12_CR77","doi-asserted-by":"publisher","first-page":"47622","DOI":"10.1074\/jbc.M305909200","volume":"278","author":"YK Kim","year":"2003","unstructured":"Kim YK, Kim SJ, Yatani A et al (2003) Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 278(48):47622\u201347628","journal-title":"J Biol Chem"},{"issue":"32","key":"12_CR78","doi-asserted-by":"publisher","first-page":"11946","DOI":"10.1073\/pnas.0510138103","volume":"103","author":"Y Tsujita","year":"2006","unstructured":"Tsujita Y, Muraski J, Shiraishi I et al (2006) Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 103(32):11946\u201311951","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"12_CR79","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1172\/JCI24682","volume":"115","author":"I Shiojima","year":"2005","unstructured":"Shiojima I, Sato K, Izumiya Y et al (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115(8):2108\u20132118","journal-title":"J Clin Invest"},{"issue":"6801","key":"12_CR80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242\u2013248","journal-title":"Nature"},{"issue":"18","key":"12_CR81","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1128\/MCB.00426-14","volume":"34","author":"C Riehle","year":"2014","unstructured":"Riehle C, Wende AR, Zhu Y et al (2014) Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Mol Cell Biol 34(18):3450\u20133460","journal-title":"Mol Cell Biol"},{"issue":"Pt B","key":"12_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.yjmcc.2015.10.015","volume":"89","author":"J Noh","year":"2015","unstructured":"Noh J, Wende AR, Olsen CD et al (2015) Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations. J Mol Cell Cardiol 89(Pt B):297\u2013305","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"12_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/cvr\/cvv234","volume":"108","author":"RT Davis 3rd","year":"2015","unstructured":"Davis RT 3rd, Simon JN, Utter M et al (2015) Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling. Cardiovasc Res 108(3):335\u2013347","journal-title":"Cardiovasc Res"},{"issue":"31","key":"12_CR84","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.1073\/pnas.1301455110","volume":"110","author":"M Volkers","year":"2013","unstructured":"Volkers M, Toko H, Doroudgar S et al (2013) Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Proc Natl Acad Sci U S A 110(31):12661\u201312666","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"12_CR85","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/105072502760143836","volume":"12","author":"S Danzi","year":"2002","unstructured":"Danzi S, Klein I (2002) Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12(6):467\u2013472","journal-title":"Thyroid"},{"issue":"6","key":"12_CR86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/105072502760143809","volume":"12","author":"WH Dillmann","year":"2002","unstructured":"Dillmann WH (2002) Cellular action of thyroid hormone on the heart. Thyroid 12(6):447\u2013452","journal-title":"Thyroid"},{"issue":"2","key":"12_CR87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-3565(25)23748-X","volume":"248","author":"JB Bedotto","year":"1989","unstructured":"Bedotto JB, Gay RG, Graham SD et al (1989) Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade. J Pharmacol Exp Ther 248(2):632\u2013636","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"12_CR88","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000159155","volume":"33","author":"O Hudlicka","year":"1996","unstructured":"Hudlicka O, Brown MD (1996) Postnatal growth of the heart and its blood vessels. J Vasc Res 33(4):266\u2013287","journal-title":"J Vasc Res"},{"issue":"5","key":"12_CR89","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0735-1097(86)80213-3","volume":"7","author":"T Feldman","year":"1986","unstructured":"Feldman T, Borow KM, Sarne DH et al (1986) Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7(5):967\u2013974","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"12_CR90","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJM198211043071901","volume":"307","author":"JC Forfar","year":"1982","unstructured":"Forfar JC, Muir AL, Sawers SA et al (1982) Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. N Engl J Med 307(19):1165\u20131170","journal-title":"N Engl J Med"},{"issue":"4","key":"12_CR91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/hrt.75.4.363","volume":"75","author":"GW Ching","year":"1996","unstructured":"Ching GW, Franklyn JA, Stallard TJ et al (1996) Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 75(4):363\u2013368","journal-title":"Heart"},{"issue":"2","key":"12_CR92","first-page":"184","volume":"14","author":"MA Lazar","year":"1993","unstructured":"Lazar MA (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14(2):184\u2013193","journal-title":"Endocr Rev"},{"issue":"6","key":"12_CR93","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M et al (1995) The nuclear receptor superfamily: the second decade. Cell 83(6):835\u2013839","journal-title":"Cell"},{"issue":"6","key":"12_CR94","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1172\/JCI114906","volume":"86","author":"MA Lazar","year":"1990","unstructured":"Lazar MA, Chin WW (1990) Nuclear thyroid hormone receptors. J Clin Invest 86(6):1777\u20131782","journal-title":"J Clin Invest"},{"issue":"6","key":"12_CR95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/105072502760143791","volume":"12","author":"CB Harvey","year":"2002","unstructured":"Harvey CB, Williams GR (2002) Mechanism of thyroid hormone action. Thyroid 12(6):441\u2013446","journal-title":"Thyroid"},{"issue":"4738","key":"12_CR96","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.3945800","volume":"231","author":"S Izumo","year":"1986","unstructured":"Izumo S, Nadal-Ginard B, Mahdavi V (1986) All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231(4738):597\u2013600","journal-title":"Science"},{"issue":"15","key":"12_CR97","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/S0021-9258(18)68584-9","volume":"263","author":"D Rohrer","year":"1988","unstructured":"Rohrer D, Dillmann WH (1988) Thyroid hormone markedly increases the mRNA coding for sarcoplasmic reticulum Ca2\u00a0+\u00a0\u2212ATPase in the rat heart. J Biol Chem 263(15):6941\u20136944","journal-title":"J Biol Chem"},{"issue":"2","key":"12_CR98","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0008-6363(98)00135-7","volume":"40","author":"A Nishiyama","year":"1998","unstructured":"Nishiyama A, Kambe F, Kamiya K et al (1998) Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle. Cardiovasc Res 40(2):343\u2013351","journal-title":"Cardiovasc Res"},{"issue":"3","key":"12_CR99","doi-asserted-by":"publisher","first-page":"E428","DOI":"10.1152\/ajpendo.00019.2002","volume":"283","author":"RE Weiss","year":"2002","unstructured":"Weiss RE, Korcarz C, Chassande O et al (2002) Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-alpha or -beta: an echocardiograph study. Am J Physiol Endocrinol Metab 283(3):E428\u2013E435","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"12_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2003.10.033","volume":"213","author":"JH Bassett","year":"2003","unstructured":"Bassett JH, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213(1):1\u201311","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"12_CR101","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1124\/jpet.103.055038","volume":"307","author":"MC Farach-Carson","year":"2003","unstructured":"Farach-Carson MC, Davis PJ (2003) Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J Pharmacol Exp Ther 307(3):839\u2013845","journal-title":"J Pharmacol Exp Ther"},{"issue":"30","key":"12_CR102","doi-asserted-by":"publisher","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K (2006) Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281(30):20666\u201320672","journal-title":"J Biol Chem"},{"issue":"2","key":"12_CR103","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1073\/pnas.0606663104","volume":"104","author":"JR McMullen","year":"2007","unstructured":"McMullen JR, Amirahmadi F, Woodcock EA et al (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 104(2):612\u2013617","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"12_CR104","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2353\/ajpath.2009.090126","volume":"175","author":"L Pretorius","year":"2009","unstructured":"Pretorius L, Du XJ, Woodcock EA et al (2009) Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 175(3):998\u20131009","journal-title":"Am J Pathol"},{"issue":"12","key":"12_CR105","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1007\/s00125-012-2720-0","volume":"55","author":"RH Ritchie","year":"2012","unstructured":"Ritchie RH, Love JE, Huynh K et al (2012) Enhanced phosphoinositide 3-kinase(p110alpha) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes. Diabetologia 55(12):3369\u20133381","journal-title":"Diabetologia"},{"issue":"12","key":"12_CR106","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","volume":"107","author":"T Shioi","year":"2003","unstructured":"Shioi T, McMullen JR, Tarnavski O et al (2003) Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107(12):1664\u20131670","journal-title":"Circulation"},{"issue":"24","key":"12_CR107","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","volume":"109","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Sherwood MC, Tarnavski O et al (2004) Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109(24):3050\u20133055","journal-title":"Circulation"},{"issue":"5","key":"12_CR108","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cardfail.2006.03.002","volume":"12","author":"A Buerger","year":"2006","unstructured":"Buerger A, Rozhitskaya O, Sherwood MC et al (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12(5):392\u2013398","journal-title":"J Card Fail"},{"issue":"23","key":"12_CR109","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1161\/01.CIR.100.23.2373","volume":"100","author":"T Matsui","year":"1999","unstructured":"Matsui T, Li L, del Monte F et al (1999) Adenoviral gene transfer of activated phosphatidylinositol 3\u2032-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100(23):2373\u20132379","journal-title":"Circulation"},{"issue":"3","key":"12_CR110","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/01.CIR.104.3.330","volume":"104","author":"T Matsui","year":"2001","unstructured":"Matsui T, Tao J, del Monte F et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104(3):330\u2013335","journal-title":"Circulation"},{"issue":"6","key":"12_CR111","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/01.RES.88.6.609","volume":"88","author":"K Yamashita","year":"2001","unstructured":"Yamashita K, Kajstura J, Discher DJ et al (2001) Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88(6):609\u2013614","journal-title":"Circ Res"},{"issue":"6","key":"12_CR112","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio Y, Nguyen T, Wencker D et al (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101(6):660\u2013667","journal-title":"Circulation"},{"issue":"5","key":"12_CR113","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.cdd.4402095","volume":"14","author":"M Ceci","year":"2007","unstructured":"Ceci M, Gallo P, Santonastasi M et al (2007) Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ 14(5):1060\u20131062","journal-title":"Cell Death Differ"},{"issue":"1","key":"12_CR114","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.111.964783","volume":"5","author":"S Araki","year":"2012","unstructured":"Araki S, Izumiya Y, Hanatani S et al (2012) Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction. Circ Heart Fail 5(1):116\u2013125","journal-title":"Circ Heart Fail"},{"issue":"5392","key":"12_CR115","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","volume":"282","author":"MH Cardone","year":"1998","unstructured":"Cardone MH, Roy N, Stennicke HR et al (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282(5392):1318\u20131321","journal-title":"Science"},{"issue":"22","key":"12_CR116","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13(22):2905\u20132927","journal-title":"Genes Dev"},{"issue":"4","key":"12_CR117","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"J Zha","year":"1996","unstructured":"Zha J, Harada H, Yang E et al (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87(4):619\u2013628","journal-title":"Cell"},{"issue":"3","key":"12_CR118","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/emboj\/19.3.349","volume":"19","author":"H Xing","year":"2000","unstructured":"Xing H, Zhang S, Weinheimer C et al (2000) 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J 19(3):349\u2013358","journal-title":"EMBO J"},{"issue":"20","key":"12_CR119","doi-asserted-by":"publisher","first-page":"21085","DOI":"10.1074\/jbc.M400063200","volume":"279","author":"SJ Gardai","year":"2004","unstructured":"Gardai SJ, Hildeman DA, Frankel SK et al (2004) Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279(20):21085\u201321095","journal-title":"J Biol Chem"},{"issue":"12","key":"12_CR120","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/nm1671","volume":"13","author":"JA Muraski","year":"2007","unstructured":"Muraski JA, Rota M, Misao Y et al (2007) Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 13(12):1467\u20131475","journal-title":"Nat Med"},{"issue":"7","key":"12_CR121","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/CIRCRESAHA.109.212035","volume":"106","author":"GA Borillo","year":"2010","unstructured":"Borillo GA, Mason M, Quijada P et al (2010) Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res 106(7):1265\u20131274","journal-title":"Circ Res"},{"issue":"8","key":"12_CR122","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI119730","volume":"100","author":"Q Li","year":"1997","unstructured":"Li Q, Li B, Wang X et al (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100(8):1991\u20131999","journal-title":"J Clin Invest"},{"issue":"9","key":"12_CR123","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/01.RES.84.9.1007","volume":"84","author":"B Li","year":"1999","unstructured":"Li B, Setoguchi M, Wang X et al (1999) Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res 84(9):1007\u20131019","journal-title":"Circ Res"},{"issue":"6","key":"12_CR124","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","volume":"50","author":"J Kajstura","year":"2001","unstructured":"Kajstura J, Fiordaliso F, Andreoli AM et al (2001) IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50(6):1414\u20131424","journal-title":"Diabetes"},{"issue":"6","key":"12_CR125","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/01.RES.0000013780.77774.75","volume":"90","author":"S Welch","year":"2002","unstructured":"Welch S, Plank D, Witt S et al (2002) Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res 90(6):641\u2013648","journal-title":"Circ Res"},{"issue":"6","key":"12_CR126","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/db09-1456","volume":"59","author":"K Huynh","year":"2010","unstructured":"Huynh K, McMullen JR, Julius TL et al (2010) Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes 59(6):1512\u20131520","journal-title":"Diabetes"},{"issue":"3","key":"12_CR127","doi-asserted-by":"publisher","first-page":"H566","DOI":"10.1152\/ajpheart.00562.2008","volume":"296","author":"DL Rigor","year":"2009","unstructured":"Rigor DL, Bodyak N, Bae S et al (2009) Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase C{beta}2 in the regulation of physiologic developmental hypertrophy and heart function. Am J Physiol Heart Circ Physiol 296(3):H566\u2013H572","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"12_CR128","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/heart.86.6.693","volume":"86","author":"AA Kotlyar","year":"2001","unstructured":"Kotlyar AA, Vered Z, Goldberg I et al (2001) Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart 86(6):693\u2013700","journal-title":"Heart"},{"issue":"12","key":"12_CR129","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1161\/01.CIR.93.12.2188","volume":"93","author":"RL Duerr","year":"1996","unstructured":"Duerr RL, McKirnan MD, Gim RD et al (1996) Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93(12):2188\u20132196","journal-title":"Circulation"},{"issue":"12","key":"12_CR130","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/oxfordjournals.eurheartj.a060839","volume":"16","author":"A Battler","year":"1995","unstructured":"Battler A, Hasdai D, Goldberg I et al (1995) Exogenous insulin-like growth factor II enhances post-infarction regional myocardial function in swine. Eur Heart J 16(12):1851\u20131859","journal-title":"Eur Heart J"},{"issue":"1","key":"12_CR131","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/01.CIR.99.1.127","volume":"99","author":"M Tajima","year":"1999","unstructured":"Tajima M, Weinberg EO, Bartunek J et\u00a0al (1999) Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation 99(1):127\u2013134","journal-title":"Circulation"},{"issue":"19","key":"12_CR132","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/01.CIR.100.19.2003","volume":"100","author":"WV Houck","year":"1999","unstructured":"Houck WV, Pan LC, Kribbs SB et al (1999) Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 100(19):2003\u20132009","journal-title":"Circulation"},{"issue":"6","key":"12_CR133","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.athoracsur.2003.12.043","volume":"77","author":"V Jayasankar","year":"2004","unstructured":"Jayasankar V, Bish LT, Pirolli TJ et al (2004) Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. Ann Thorac Surg 77(6):2122\u20132129. discussion 2129","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"12_CR134","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","volume":"54","author":"A Colao","year":"2001","unstructured":"Colao A, Marzullo P, Di Somma C et al (2001) Growth hormone and the heart. Clin Endocrinol 54(2):137\u2013154","journal-title":"Clin Endocrinol"},{"issue":"11","key":"12_CR135","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1006\/jmcc.1999.1036","volume":"31","author":"J Ren","year":"1999","unstructured":"Ren J, Samson WK, Sowers JR (1999) Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31(11):2049\u20132061","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"12_CR136","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4161\/cc.6.8.4124","volume":"6","author":"JR McMullen","year":"2007","unstructured":"McMullen JR, Jay PY (2007) PI3K(p110alpha) Inhibitors as anti-cancer agents: minding the heart. Cell Cycle 6(8):910\u2013913","journal-title":"Cell Cycle"},{"issue":"1","key":"12_CR137","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1172\/JCI62837","volume":"123","author":"RJ Hajjar","year":"2013","unstructured":"Hajjar RJ (2013) Potential of gene therapy as a treatment for heart failure. J Clin Invest 123(1):53\u201361","journal-title":"J Clin Invest"},{"issue":"8","key":"12_CR138","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1085","volume":"10","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic P, Blankinship MJ, Allen JM et al (2004) Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10(8):828\u2013834","journal-title":"Nat Med"},{"issue":"1","key":"12_CR139","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A et al (2015) Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res 116(1):35\u201345","journal-title":"Circ Res"},{"issue":"2 Pt 1","key":"12_CR140","first-page":"E219","volume":"267","author":"A Cittadini","year":"1994","unstructured":"Cittadini A, Cuocolo A, Merola B et al (1994) Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Phys 267(2 Pt 1):E219\u2013E225","journal-title":"Am J Phys"},{"issue":"10","key":"12_CR141","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.110.239111","volume":"108","author":"R Katare","year":"2011","unstructured":"Katare R, Caporali A, Zentilin L et al (2011) Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 108(10):1238\u20131251","journal-title":"Circ Res"},{"key":"12_CR142","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1038\/ncomms6705","volume":"5","author":"G Sapra","year":"2014","unstructured":"Sapra G, Tham YK, Cemerlang N et al (2014) The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice. Nat Commun 5:5705","journal-title":"Nat Commun"},{"key":"12_CR143","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12967-015-0444-x","volume":"13","author":"JB Moreira","year":"2015","unstructured":"Moreira JB, Wohlwend M, Alves MN et al (2015) A small molecule activator of AKT does not reduce ischemic injury of the rat heart. J Transl Med 13:76","journal-title":"J Transl Med"},{"issue":"6","key":"12_CR144","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCRESAHA.108.192872","volume":"104","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, Srivastava D (2009) MicroRNA regulation of cardiovascular development. Circ Res 104(6):724\u2013732","journal-title":"Circ Res"},{"issue":"1","key":"12_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00428-007-0532-2","volume":"452","author":"S Sassen","year":"2008","unstructured":"Sassen S, Miska EA, Caldas C (2008) MicroRNA\u00a0\u2013 implications for cancer. Virchows Arch 452(1):1\u201310","journal-title":"Virchows Arch"},{"issue":"3","key":"12_CR146","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.hlc.2011.11.002","volume":"21","author":"BC Bernardo","year":"2012","unstructured":"Bernardo BC, Charchar FJ, Lin RC et al (2012) A MicroRNA guide for clinicians and basic scientists: background and experimental techniques. Heart Lung Circ 21(3):131\u2013142","journal-title":"Heart Lung Circ"},{"issue":"13","key":"12_CR147","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.4155\/fmc.15.107","volume":"7","author":"BC Bernardo","year":"2015","unstructured":"Bernardo BC, Ooi JY, Lin RC et al (2015) miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem 7(13):1771\u20131792","journal-title":"Future Med Chem"},{"issue":"2","key":"12_CR148","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"6","key":"12_CR149","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1073\/pnas.0710228105","volume":"105","author":"J-F Chen","year":"2008","unstructured":"Chen J-F, Murchison EP, Tang R et al (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 105(6):2111\u20132116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"12_CR150","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/CIRCULATIONAHA.108.769984","volume":"118","author":"PA Costa Martins da","year":"2008","unstructured":"da Costa Martins PA, Bourajjaj M, Gladka M et al (2008) Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118(15):1567\u20131576","journal-title":"Circulation"},{"issue":"6","key":"12_CR151","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.yjmcc.2007.04.004","volume":"42","author":"M Tatsuguchi","year":"2007","unstructured":"Tatsuguchi M, Seok HY, Callis TE et al (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42(6):1137\u20131141","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"12_CR152","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116(3):258\u2013267","journal-title":"Circulation"},{"issue":"8","key":"12_CR153","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","volume":"121","author":"EM Small","year":"2010","unstructured":"Small EM, Frost RJA, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121(8):1022\u20131032","journal-title":"Circulation"},{"issue":"7224","key":"12_CR154","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J et\u00a0al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980\u2013984","journal-title":"Nature"},{"issue":"35","key":"12_CR155","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E Rooij van","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105(35):13027\u201313032","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"12_CR156","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis TE, Pandya K, Seok HY et al (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119(9):2772\u20132786","journal-title":"J Clin Invest"},{"issue":"5","key":"12_CR157","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care A, Catalucci D, Felicetti F et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13(5):613\u2013618","journal-title":"Nat Med"},{"issue":"2","key":"12_CR158","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4155\/fmc.13.196","volume":"6","author":"JY Ooi","year":"2014","unstructured":"Ooi JY, Bernardo BC, McMullen JR (2014) The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med Chem 6(2):205\u2013222","journal-title":"Future Med Chem"},{"issue":"43","key":"12_CR159","doi-asserted-by":"publisher","first-page":"17615","DOI":"10.1073\/pnas.1206432109","volume":"109","author":"BC Bernardo","year":"2012","unstructured":"Bernardo BC, Gao XM, Winbanks CE et al (2012) Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A 109(43):17615\u201317620","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"12_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090337","volume":"9","author":"BC Bernardo","year":"2014","unstructured":"Bernardo BC, Gao XM, Tham YK et al (2014) Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS One 9(2):e90337","journal-title":"PLoS One"},{"issue":"12","key":"12_CR161","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1096\/fj.14-253856","volume":"28","author":"BC Bernardo","year":"2014","unstructured":"Bernardo BC, Nguyen SS, Winbanks CE et al (2014) Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. FASEB J 28(12):5097\u20135110","journal-title":"FASEB J"},{"key":"12_CR162","doi-asserted-by":"publisher","first-page":"22442","DOI":"10.1038\/srep22442","volume":"6","author":"BC Bernardo","year":"2016","unstructured":"Bernardo BC, Nguyen SS, Gao XM et al (2016) Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload. Sci Rep 6:22442","journal-title":"Sci Rep"},{"issue":"20","key":"12_CR163","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1113\/JP272512","volume":"594","author":"BC Bernardo","year":"2016","unstructured":"Bernardo BC, Ooi JYY, Matsumoto A et al (2016) Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs. J Physiol 594(20):5959\u20135974","journal-title":"J Physiol"},{"issue":"24","key":"12_CR164","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1161\/CIRCULATIONAHA.106.675041","volume":"115","author":"U Wisloff","year":"2007","unstructured":"Wisloff U, Stoylen A, Loennechen JP et al (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115(24):3086\u20133094","journal-title":"Circulation"}],"container-title":["Advances in Experimental Medicine and Biology","Exercise for Cardiovascular Disease Prevention and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-4304-8_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:59:21Z","timestamp":1750957161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-4304-8_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811043031","9789811043048"],"references-count":164,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-4304-8_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"3 November 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}